Johnson Investment Counsel Has Trimmed Position in Vertex Pharmaceuticals Incorporat (VRTX) by $456,473; As Lear (LEA) Shares Rose, Alphamark Advisors Decreased Stake

February 24, 2018 - By Vivian Park

Johnson Investment Counsel Inc decreased its stake in Vertex Pharmaceuticals Incorporat (VRTX) by 22.46% based on its latest 2017Q3 regulatory filing with the SEC. Johnson Investment Counsel Inc sold 3,023 shares as the company’s stock rose 33.61% with the market. The institutional investor held 10,438 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.59 million, down from 13,461 at the end of the previous reported quarter. Johnson Investment Counsel Inc who had been investing in Vertex Pharmaceuticals Incorporat for a number of months, seems to be less bullish one the $42.12B market cap company. The stock increased 5.27% or $8.31 during the last trading session, reaching $165.9. About 1.59 million shares traded. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 45.69% since February 24, 2017 and is uptrending. It has outperformed by 28.99% the S&P500.

Alphamark Advisors Llc decreased its stake in Lear (LEA) by 7.91% based on its latest 2017Q3 regulatory filing with the SEC. Alphamark Advisors Llc sold 1,823 shares as the company’s stock rose 0.77% with the market. The institutional investor held 21,224 shares of the o.e.m. company at the end of 2017Q3, valued at $3.67 million, down from 23,047 at the end of the previous reported quarter. Alphamark Advisors Llc who had been investing in Lear for a number of months, seems to be less bullish one the $12.66B market cap company. The stock decreased 0.02% or $0.04 during the last trading session, reaching $189.13. About 607,780 shares traded or 7.96% up from the average. Lear Corporation (NYSE:LEA) has risen 28.33% since February 24, 2017 and is uptrending. It has outperformed by 11.63% the S&P500.

Analysts await Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to report earnings on April, 26. They expect $0.27 earnings per share, up 107.69% or $0.14 from last year’s $0.13 per share. VRTX’s profit will be $68.55 million for 153.61 P/E if the $0.27 EPS becomes a reality. After $0.32 actual earnings per share reported by Vertex Pharmaceuticals Incorporated for the previous quarter, Wall Street now forecasts -15.63% negative EPS growth.

Among 30 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 26 have Buy rating, 0 Sell and 4 Hold. Therefore 87% are positive. Vertex Pharmaceuticals had 97 analyst reports since July 31, 2015 according to SRatingsIntel. Maxim Group maintained it with “Buy” rating and $19500 target in Wednesday, July 19 report. The rating was upgraded by Raymond James on Wednesday, July 19 to “Outperform”. The firm earned “Buy” rating on Thursday, February 1 by Leerink Swann. Oppenheimer upgraded Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Friday, June 2 to “Outperform” rating. The stock has “Overweight” rating by Barclays Capital on Wednesday, July 19. The stock has “Overweight” rating by Morgan Stanley on Friday, February 2. The rating was downgraded by UBS to “Hold” on Wednesday, July 19. Vetr upgraded it to “Hold” rating and $142.57 target in Monday, August 24 report. The firm earned “Buy” rating on Friday, January 5 by Bank of America. The firm earned “Hold” rating on Wednesday, July 19 by H.C. Wainwright.

Johnson Investment Counsel Inc, which manages about $8.19 billion and $3.78 billion US Long portfolio, upped its stake in Schwab Us Large (SCHX) by 18,668 shares to 246,258 shares, valued at $14.79M in 2017Q3, according to the filing. It also increased its holding in Coca Cola Company (NYSE:KO) by 21,786 shares in the quarter, for a total of 966,004 shares, and has risen its stake in Vanguard Ftse All (VEU).

Since August 31, 2017, it had 0 insider purchases, and 43 selling transactions for $118.28 million activity. 99,563 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares with value of $15.63M were sold by LEIDEN JEFFREY M. Shares for $580,304 were sold by Chodakewitz Jeffrey on Monday, February 5. MCGLYNN MARGARET G had sold 20,000 shares worth $3.25M on Monday, January 22. ALTSHULER DAVID sold 1,796 shares worth $287,360. The insider Silva Paul M sold 5,435 shares worth $891,487. Bhatia Sangeeta N. had sold 10,753 shares worth $1.68M on Friday, January 5.

Investors sentiment increased to 1.62 in Q3 2017. Its up 0.11, from 1.51 in 2017Q2. It is positive, as 32 investors sold VRTX shares while 151 reduced holdings. 79 funds opened positions while 217 raised stakes. 231.42 million shares or 0.04% more from 231.33 million shares in 2017Q2 were reported. Kistler holds 0.04% or 665 shares in its portfolio. Parkside Bancshares And Tru holds 0.02% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 360 shares. & Com owns 0.44% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 8,950 shares. State Of Alaska Department Of Revenue holds 0.05% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 6,070 shares. Scotia Capital Incorporated holds 0.04% or 16,801 shares in its portfolio. State Street owns 11.22M shares or 0.15% of their US portfolio. Natixis reported 20,280 shares. Moreover, Parametrica has 0.13% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Advisors Asset Mgmt reported 0.03% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Bessemer Group has invested 0% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Prudential Public Limited Com accumulated 1,813 shares or 0% of the stock. Martingale Asset Mngmt Ltd Partnership invested in 0.03% or 14,305 shares. Evercore Wealth Mgmt Limited Com reported 3,055 shares stake. Columbus Circle Invsts accumulated 452,645 shares. Toronto Dominion Natl Bank reported 99,771 shares or 0.05% of all its holdings.

Analysts await Lear Corporation (NYSE:LEA) to report earnings on April, 25. They expect $4.88 earnings per share, up 14.29% or $0.61 from last year’s $4.27 per share. LEA’s profit will be $326.58M for 9.69 P/E if the $4.88 EPS becomes a reality. After $4.38 actual earnings per share reported by Lear Corporation for the previous quarter, Wall Street now forecasts 11.42% EPS growth.

Since September 18, 2017, it had 0 insider purchases, and 13 selling transactions for $47.64 million activity. $494,841 worth of Lear Corporation (NYSE:LEA) shares were sold by FOSTER JONATHAN F. 5,373 Lear Corporation (NYSE:LEA) shares with value of $1.02M were sold by BURGESS SHARI L. $690,025 worth of Lear Corporation (NYSE:LEA) was sold by WALLACE HENRY D G. Another trade for 21,706 shares valued at $4.13M was sold by Orsini Frank C. 17,006 shares were sold by STEPHENS MEL, worth $3.28M. Kunkel Jay K. sold $1.27M worth of stock or 6,694 shares.

Alphamark Advisors Llc, which manages about $314.05M and $235.94 million US Long portfolio, upped its stake in Firsttr Riverfront Dyn by 5,335 shares to 6,865 shares, valued at $433,000 in 2017Q3, according to the filing. It also increased its holding in Ishares Ibonds Dec 201 by 19,984 shares in the quarter, for a total of 201,722 shares, and has risen its stake in Janus Short Duration I.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>